Font Size: a A A
Keyword [tyrosine kinase inhibitor]
Result: 81 - 100 | Page: 5 of 10
81. Study On The Anti-Tumor Activities And Mechanisms Of A Novel Multi-target Tyrosine Kinase Inhibitor, AL-8326
82. The Basic Research Of11C-PD153035PET/CT Imaging On Lung Adenocarcinoma
83. Mechanism Of EGFR Tyrosine Kinase Inhibitor-induced Injury In Intestinal Epithelialium
84. Design And Synthesis Of Indole Derivatives As Vegfr-2Tyrosine Kinase Inhibitors
85. A Study About Anticancer Effect Of BZG-4000on A Hepatocellular Carcinoma Xenograft Model
86. Caveolin-1 Decreases The Sensibility To TKIs In Non-small Cell Lung Cancer Harboring EGFR Mutations
87. Clinical Observation Of Targeted Drugs As A Therapy On Advanced Non-small Cell Lung Cancer
88. Erlotinib Enhanced The CIK Cell-mediated Lysis To Lung Adenocarcinoma HCC827 Cells
89. Radiosensitizing And Its Mechanism Study Of -et Small Molecule Tyrosine Kinase Inhibitor ARQ197 On Lung Adenocarcinoma Cell Line
90. Clinical Efficacy Of Third-Line Tyrpsine Kinase Inhibitors For Advanced Gastrointestinal Stromal Tumors After Failure Of Imatinib And Sunitinib:a Meta-Analysis
91. Constrution Of FOXQ1-silenced Colorectal Cancer Cell And The Research Of Relationship Between FOXQ1 And EGFR Gene
92. Efficiency And Safety Of Sequential Treatment Of Icotinib With Chemotherapy In Patients Undergoing Resection Of EGFR Mutation-positive Non-small Cell Lung Cancer
93. Design, Synthesis And Activity Evaluation Of Novel Protein Tyrosine Kinase Inhibitors Containing Sulfone And Sulfoxide Structures
94. Synthesis Of The Anti-Cancer Agent Gefitinib
95. Inhibition Of Phosphorylation Of Caveolin-1 On The Effects Of Lung Injury Induced By Ventilation
96. The Relationship With Different Status Of Epidermal Growth Factor Receptor Gene, Clinicopathological Characteristics,prognosis And Therapeutic Effect Of Patients With Non-small Cell Lung Cancer In Qinghai
97. The Clinical Observation Of Therapeutic Regimens For Slow Progression Advanced NSCLC After First-line EGFR-TKI Therapy
98. Analysis On Clinical Effect Of CIK Combined With TKIs In Treatment Of Non-small Cell Lung Cancer Patients With TKIs Resistance
99. Synthetic Of Bruton’s Tyrosine Kinase Inhibitor (-)-CD055
100. The Efficacy Comparison Of Icotinib And Gefitinib In Stage Ⅳ Lung Adenocarcinoma Patients With EGFR Sensitive Gene Mutation
  <<First  <Prev  Next>  Last>>  Jump to